retatrutide phase 2 type 2 diabetes weight loss 2024 trial 🚨Breaking: Retatrutide's first 3 T2D data just dropped. ▸ A1C: −2.0% at 40 weeks ▸ Weight: Eli Lilly infiltrates anti-obesity market

Modern Food Environments Confuse Portion Size and Appetite Scientific studies show: We consistently underestimate portion size Larger portions lead to automatic overeating Ultra-processed foods overstimulate reward pathways (dopamine) and weaken satiety Smoothies, bowls, and wraps often contain 6001,200 calories Eating while distracted increases intake by 1530% The Bottom Line: Your biology and our modern environment make accurate calorie awareness nearly impossible

Cleansing your face twice daily removes dirt, oil, impurities, pollution, and makeup on your skin

Bottom Line The Path to $1 Trillion Current State (Nov 2025): Stock Price: ~$990 Market Cap: ~$885-930B Distance to $1T: ~7-13% away Catalysts Ahead: Orforglipron approval (March 2026 expected) Continued GLP-1 market expansion Kisunla (Alzheimer's) adoption ramp Pipeline readouts in oncology and immunology For Long-Term Investors: Volatility is part of the journey

Does GHK-Cu work better injected or applied topically

Your Wellness Routine Deserves a Gut-Healthy Prebiotic Bar Protein bars won't transform your health overnight